Clinical Trial Update: Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating IxCell hUC-MSC-S (human umbilical cord mesenchymal stem cells) for ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• IxCell hUC-MSC-S

Snippet

Sponsor: Shanghai IxCell Biotechnology Co., LTD | Conditions: Ischemic Stroke | Phase 1 | Status: COMPLETED